Obesity & Overweight
Metabolic·MeSH: Overweight
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
3 drugs in development·2 companies·27 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| enobosarm | VERU INC. (VERU) |
Phase 2(1)
| Drug | Company |
|---|---|
| semaglutide weekly | VERU INC. (VERU) |
N/A(1)
| Drug | Company |
|---|---|
| Incretin-Based Treatment | Merus N.V. (MRUS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Obesity & Overweight?
BioSniper tracks 3 drugs in development for Obesity & Overweight across 2 companies.
How many clinical trials target Obesity & Overweight?
There are 27 clinical trials targeting Obesity & Overweight tracked by BioSniper.
What is the prevalence of Obesity & Overweight?
The estimated prevalence of Obesity & Overweight is approximately 42000.0 per 100,000 population.
Deep-dive into Obesity & Overweight
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis